FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, specifically pharmacology, and may be used for correction of immune disorders in pathological conditions associated with Th1-dependent type of immune response (chronic, smoldering and recurrent infectious, as well as oncological diseases).
EFFECT: water-soluble polysaccharides of molecular weight 310 and 490 kDa recovered from compendial raw calendula are macrophage inflammatory properties activators, and Th-dependent type of immune response, and may extend the range of herbal products able to stimulate immune response in infectious-inflammatory processes and oncological disease.
2 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
IMMUNOMODULATORY DRUG | 2010 |
|
RU2421232C1 |
MEDICATION POSSESSING IMMUNOMODULATING ACTIVITY | 2010 |
|
RU2423141C1 |
MEANS OF IMMUNOMODULATING ACTIVITY | 2017 |
|
RU2657819C1 |
AGENT HAVING IMMUNOMODULATORY ACTIVITY | 2018 |
|
RU2697526C1 |
AGENT HAVING IMMUNOMODULATORY ACTIVITY | 2019 |
|
RU2734420C1 |
AGENT OF IMMUNOMODULATING ACTIVITY | 2007 |
|
RU2329821C1 |
AGENT OF IMMUNOMODULATING ACTIVITY | 2007 |
|
RU2337700C1 |
AGENT OF HUMIC NATURE OF IMMUNOMODULATING ACTIVITY | 2017 |
|
RU2662094C1 |
IMMUNOMODULATING HUMIC AGENT | 2020 |
|
RU2756353C1 |
HUMIC SUBSTANCE HAVING IMMUNOMODULATORY ACTIVITY | 2019 |
|
RU2716504C1 |
Authors
Dates
2012-12-27—Published
2011-10-19—Filed